Op-Ed
Commentary first published by another outlet and republished here.
-
Op-Ed
The Supreme Court has emboldened the CFPB, threatening American consumers
The Supreme Court’s recent ruling will only embolden CFPB Director Rohit Chopra, who has increasingly instituted overly broad regulatory actions.
Originally published inThe Hill
-
Op-Ed
CFPB’s latest overreach threatens to nationalize consumer finance
In a bold move that may reshape the U.S. consumer finance landscape, Rohit Chopra’s Consumer Financial Protection Bureau has issued Consumer Financial Protection Circular 2024-01, marking a significant overreach into how Americans access financial services. This…
Originally published inAmerican Banker
-
Op-Ed
New Mexico Parents Want Gender Ideology Out of School Curriculum
Co-authored by Judy Pino and Patrick M. Brenner. Originally published at abqjournal.com on February 18, 2024. Radical gender ideology is running rampant through New Mexico’s public schools. State-funded after-school clubs that encourage children to explore LGBTQ+ identities…
Originally published inAlbuquerque Journal
-
Op-Ed
Colorado’s Intrastate Minimum-Wage Compacts Will Hurt the State
Experience shows that businesses pass on increased costs to consumers, hurting the very people wage hikes are supposed to help.
Originally published inNational Review
-
Op-Ed
Who’s protecting consumers from the Consumer Financial Protection Bureau?
If CFPB found a financial institution had suffered a data breach of a similar magnitude, the fines and fees would be astronomical.
Originally published inFox News
-
Op-Ed
A public bank could crowd out community-based financial institutions
The 2022 passage of House Bill 132, which set a stringent cap of 36% on interest rates for consumer loans, is having its intended and significant repercussions on New Mexico’s financial landscape. This was no accident:…
Originally published inAlbuquerque Journal
-
Op-Ed
Excessive regulation is fueling a health care crisis in Utah
Recent research has shown that health care consolidations not only lower costs for health care consumers but also improve multiple indicators of quality patient care.
Originally published inDeseret News
-
Op-Ed
The high cost of prescription drug price controls
Components of the Inflation Reduction Act have the very real potential of inflating drug prices with arbitrary price controls. Consumers will pay the price.
Originally published inThe Washington Times
-
Op-Ed
A case for a permanent fund dividend
New Mexico stands on the cusp of a golden era, with its oil and gas boom enriching the state’s coffers to unprecedented levels. Now is the time to ensure that this wealth directly benefits the very…
Originally published inLas Cruces Sun-News